|29.35||-2.52 / -7.91%|
Data as of Oct 17
|31.26||+1.91 / +6.51%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 34.00, with a high estimate of 51.00 and a low estimate of 26.00. The median estimate represents a +15.84% increase from the last price of 29.35.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.